Men benefit from vaccinating girls against HPV but remain at risk of some cancers

May 12, 2015, British Medical Journal
HPV
HPV4 (Gardasil) vaccine. Credit: UMich

Men benefit indirectly from vaccinating girls against human papillomavirus (HPV), but remain at risk of cancers associated with the virus, finds a study from The Netherlands published in The BMJ this week.

Human papillomavirus is one of the most common and many countries vaccinate girls to protect them against in later life.

Studies indicate that the is also effective in preventing certain cancers in as well as women, prompting calls to vaccinate not only girls but also boys against HPV. Only a few countries have so far recommended universal vaccination of boys. These include Australia, Austria, two Canadian provinces, and the United States.

Johannes Bogaards and Johannes Berkhof at VU University Medical Centre in Amsterdam, with colleagues, set out to estimate the benefits to men if boys are vaccinated along with girls against HPV.

They used data from the Dutch national cancer registry and epidemiological studies to assess the impact on cancers associated with the virus (anal, penile, and some ) among heterosexual men and in men who have sex with men.

Before HPV vaccination, about 15 quality adjusted life years or QALYs (a combined measure of quality and quantity of life) per thousand men were lost to preventable cancers associated with HPV in The Netherlands.

This burden would fall by 37% if the vaccine uptake among girls remains at the current level of 60% - and around 800 boys would need to be vaccinated to prevent one additional case of cancer among men.

If vaccine uptake among girls increases to 90%, the burden of HPV related cancer in men would fall by 66% - and over 1,700 boys would need to be vaccinated to prevent one additional case.

The authors point out that these numbers are substantially less favourable than those that motivated vaccination of girls to protect women against cervical cancer. And they say the efficiency of vaccinating boys "needs ultimate assessment in a health economic evaluation."

They suggest that authorities "should, first and foremost strive to vaccinate as many girls as possible" but say inclusion of boys into preadolescent HPV vaccination programmes is warranted "once the incremental costs of vaccination conform to society's willingness to pay in comparison with the incremental health effects."

And they conclude that protection of women "should no longer be the sole public health objective of any HPV vaccination programme."

In an accompanying editorial, Karen Canfell, Director of Cancer Research at Cancer Council NSW in Australia, says the findings "reinforce those of prior analyses that found that adding boys to established vaccination programmes in girls becomes less cost effective as female coverage increases."

She argues that although the shift in focus in richer countries towards considering vaccination of is appropriate, the current priority in low and middle income countries should be cervical cancer prevention via the development of integrated programmes for vaccinating young and screening older women.

"Based on experience in developed countries, this will also provide benefits for men through indirect vaccine protection," she concludes.

Explore further: Why we should vaccinate boys against HPV as well as girls

More information: Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis, The BMJ, www.bmj.com/cgi/doi/10.1136/bmj.h2016

Related Stories

Why we should vaccinate boys against HPV as well as girls

July 30, 2014
Gillian Prue, from the School of Nursing and Midwifery at Queen's University of Belfast, says that the human papillomavirus (HPV) infection is common in men and can lead to genital warts and the development of some head and ...

HPV vaccination of adolescent boys may be cost-effective for preventing oropharyngeal cancer

April 13, 2015
A new study indicates that vaccinating 12-year-old boys against the humanpapilloma virus (HPV) may be a cost-effective strategy for preventing oropharyngeal squamous cell cancer, a cancer that starts at the back of the throat ...

Urging HPV vaccine for boys could protect more people at same price

March 11, 2015
A Duke University study proposes a strategy to better use limited public health care dollars for protecting more people from a sexually transmitted infection called human papillomavirus (HPV) and the cancers it can cause.

President's panel calls for more girls, boys to get HPV vaccine

February 10, 2014
(HealthDay)—Too few American girls and boys are getting vaccinated against the cancer-causing human papillomavirus (HPV), the President's Cancer Panel reported Monday.

HPV vaccination for school boys not yet cost-effective

July 14, 2014
HPV vaccination of New Zealand school boys is not yet a value-for-money option, according to a study just published by the University of Otago, Wellington.

Study supports HPV vaccination guidelines

April 21, 2015
(HealthDay)—New research finds that young women who get the HPV vaccine gain significant protection against infection in three parts of the body if they haven't already been exposed to the human papillomavirus.

Recommended for you

Scientists sharpen the edges of cancer chemotherapy with CRISPR

July 13, 2018
Tackling unsolved problems is a cornerstone of scientific research, propelled by the power and promise of new technologies. Indeed, one of the shiniest tools in the biomedical toolkit these days is the genome editing system ...

Looking at the urine and blood may be best in diagnosing myeloma

July 13, 2018
When it comes to diagnosing a condition in which the plasma cells that normally make antibodies to protect us instead become cancerous, it may be better to look at the urine as well as the serum of our blood for answers, ...

Massive genome havoc in breast cancer is revealed

July 12, 2018
In cancer cells, genetic errors wreak havoc. Misspelled genes, as well as structural variations—larger-scale rearrangements of DNA that can encompass large chunks of chromosomes—disturb carefully balanced mechanisms that ...

Study shows biomarker panel boosts lung cancer risk assessment for smokers

July 12, 2018
A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon smoking history, capturing risk for people who have ever smoked, not only for heavy smokers, an international ...

Discovering the mechanisms that underlie prostate cancer

July 12, 2018
New research has uncovered insights into the mechanisms that underlie prostate cancer, providing potential targets for new cancer therapies.

New method reveals how well cancer drugs hit their targets

July 12, 2018
Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets inside the body. It shows individual cancer cells in a tumour in real time, revealing which cells interact with the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.